APA (7th ed.) Citation

Darlington, A., Tello-Montoliu, A., Rollini, F., Ueno, M., Ferreiro, J. L., Patel, R., . . . Angiolillo, D. J. (2014). Pharmacodynamic effects of standard dose prasugrel versus high dose clopidogrel in non-diabetic obese patients with coronary artery disease. Thrombosis and haemostasis, 111(2), 258. https://doi.org/10.1160/TH13-07-0529

Chicago Style (17th ed.) Citation

Darlington, Andrew, et al. "Pharmacodynamic Effects of Standard Dose Prasugrel Versus High Dose Clopidogrel in Non-diabetic Obese Patients with Coronary Artery Disease." Thrombosis and Haemostasis 111, no. 2 (2014): 258. https://doi.org/10.1160/TH13-07-0529.

MLA (9th ed.) Citation

Darlington, Andrew, et al. "Pharmacodynamic Effects of Standard Dose Prasugrel Versus High Dose Clopidogrel in Non-diabetic Obese Patients with Coronary Artery Disease." Thrombosis and Haemostasis, vol. 111, no. 2, 2014, p. 258, https://doi.org/10.1160/TH13-07-0529.